PREVALENCE OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS IN PATIENTS HOSPITALIZED FOR HEART FAILURE

被引：0
|
作者：
Lanati, G.
Aschieri, D.
Di Dio, M.
Calabro, D.
Mori, M.
Piepoli, M.
Rusticali, G.
机构：
[1] UOSD Cardiol & Riabilitaz Cardiol, Castelsangiovanni, Italy
[2] UOC Cardiol & UTIC, Piacenza, Italy
[3] UO Med Nucl, Piacenza, Italy
[4] Policlin San Donato, Milan, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P208
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A PRECLINICAL CASE OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS: A COMMONLY MISDIAGNOSED CATEGORY OF HEART FAILURE
    Prabhakar, Akruti Patel
    Agarwal, Ajay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2553 - 2553
  • [42] Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction
    Griffin, Jan M.
    Maurer, Mathew S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (01) : 59 - 66
  • [43] A Straining Heart: Transthyretin Amyloidosis as a Cause of Heart Failure
    Tender-Vieira, Joana
    Pinto, Claudemira
    Matias, Paula
    Marques, Pedro
    Almeida, Jorge S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [44] Riociguat in transthyretin cardiac amyloidosis - experiences from a prospective heart failure registry
    Duca, F. Franz
    Zotter-Tufaro, C.
    Binder, C.
    Kammerlander, A. A.
    Boerries, B.
    Agis, H.
    Kain, R.
    Mascherbauer, J.
    Bonderman, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 461 - 462
  • [45] Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis
    Okamoto, Nao
    Kubo, Toru
    Nakashima, Yasuteru
    Ochi, Yuri
    Takahashi, Asa
    Baba, Yuichi
    Hirota, Takayoshi
    Yamasaki, Naohito
    Kitaoka, Hiroaki
    INTERNAL MEDICINE, 2020, 59 (03) : 339 - 343
  • [46] Tc99m PYP scintigraphy to diagnose transthyretin cardiac amyloidosis in patients with heart failure
    Volodarsky, I.
    Fabrikant, J.
    Shimoni, S.
    Tshori, S.
    Haberman, D.
    Zilberman, L.
    Fuginferov, I.
    George, J.
    Livschitz, S.
    Goland, S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 575 - 575
  • [47] Cardiac Amyloidosis A Rare Disease in Older Adults Hospitalized for Heart Failure?
    Griffin, Jan M.
    Maurer, Mathew S.
    CIRCULATION-HEART FAILURE, 2019, 12 (06)
  • [48] Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction
    Cavusoglu, Y.
    Murat, S.
    Sivrikoz, I. A.
    Yalvac, H. E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 95 - 95
  • [49] Quality of life in patients with transthyretin amyloidosis accompanied by congestive heart failure
    Lovley, A.
    Kessler, A. Sikora
    Yarlas, A.
    Guthrie, S. D.
    Pollock, M.
    White, M. K.
    Mccausland, K. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 144 - 145
  • [50] Routine Ambulatory Heart Rhythm Monitoring in Patients With Transthyretin Cardiac Amyloidosis
    Dale, Zack
    Rashdan, Lana
    Chandrashekar, Pranav
    Elman, Miriam
    Heitner, Stephen B.
    Nazer, Babak
    Masri, Ahmad
    CIRCULATION, 2020, 142
12345